{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-003840","form_type":"8-K","ticker":null,"cik":"0001852536","company_name":"Redox International Group, Corp.","filed_at":"2024-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.852177+00:00","generated_at":"2026-06-01T08:18:52.557864+00:00","sec_items":["5.01","5.02","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Intorio Corp. reports change of control; founder sells 89% stake; new CEO appointed","bullets":["Founder Gagi Gogolashvili sold 2,000,000 shares (89% of outstanding) to six accredited investors on May 16, 2024.","Gogolashvili resigned as CEO, President, and director; Han-Wen Ou appointed CEO, CFO, Secretary and sole Director.","Company address changed from Tbilisi, Georgia to 17875 Von Karman Avenue, Irvine, California 92614.","Dr. Han-Wen Ou holds degrees in functional medicine and clinical nutrition; previously resident at Taipei Veterans General Hospital."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-003840","json":"https://secwatch.observer/filing/0001683168-24-003840.json","markdown":"https://secwatch.observer/filing/0001683168-24-003840.md","text":"https://secwatch.observer/filing/0001683168-24-003840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/intorio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:18:52.557864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b937d5dd3","claim":"Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director at Redox International Group, Corp..","evidence_excerpt":"Dr. Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer, Chief Financial Officer, Secretary and sole Director"}],"fact_type":"executive_change"},{"claim_id":"a087cfcd16862ac2b2dd4fd86350761864dc392c","claim":"Redox International Group, Corp. underwent a change of control (closed 2024-05-16).","evidence_excerpt":"Effective May 16, 2024, Gagi Gogolashvili, the previous sole officer and director and majority shareholder of Intorio, Corp. (the “Company”), entered into a stock purchase agreements for the sale of 2,000,000 shares of Common Stock of the Company, representing approximately 89% of the issued and outstanding shares of Common Stock of the Company as of such date","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Closing","value":"2024-05-16"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}